Highly automated QT measurement techniques in 7 thorough QT studies implemented under ICH E14 guidelines.
Highly automated QT measurement techniques in 7 thorough QT studies implemented under ICH E14 guidelines.
复制标题
DOI:
10.1111/j.1542-474x.2010.00402.x
复制
发表时间:
2011-01
期刊:
影响因子:
--
通讯作者:
Zareba W
中科院分区:
文献类型:
--
作者:
Couderc JP;Garnett C;Li M;Handzel R;McNitt S;Xia X;Polonsky S;Zareba W
Thorough QT (TQT) studies are designed to evaluate potential effect of a novel drug on the ventricular repolarization process of the heart using QTc prolongation as a surrogate marker for torsades de pointes. The current process to measure the QT intervals from the thousands of electrocardiograms is lengthy and expensive. In this study, we propose a validation of a highly-automatic QT interval measurement (HA-QT) method. We applied a HA-QT measurement method to the data from seven TQT studies. We investigated both the placebo and baseline-adjusted QTc interval prolongation induced by moxifloxacin (positive control drug) at the time of expected peak concentration. The comparative analysis evaluated the time course of moxifloxacin-induced QTc prolongation in one study as well. The absolute HA-QT data were longer than the FDA-approved QTc data. This trend was not different between ECGs from the moxifloxacin and placebo arms: 9.6±24msec on drug and 9.8±25msec on placebo. The difference between methods vanished when comparing the placebo-baseline-adjusted QTc prolongation (1.4±2.8msec, p=0.4). The differences in precision between the HA-QT and the FDA-approved measurements were not statistically different from zero: 0.1±0.1msec (p=0.7). Also, the time course of the moxifloxacin-induced QTc prolongation adjusted for placebo was not statistically different between measurements methods.